Advertisement
Home »

SGN-CD228A is an investigational CD228-directed antibody-drug conjugate with potent antitumor activity across a wide spectrum of preclinical solid tumor models.

Feb 20, 2023

ABOUT THE CONTRIBUTORS

  • Rebecca Mazahreh

    Seagen Inc., Bothell, WA, United States.

    Marsha L Mason

    Seagen Inc., Bothell, WA, United States.

    John J Gosink

    Seagen Inc., Bothell, WA, United States.

    Devra J Olson

    Seagen Inc., Bothell, WA, United States.

    Robert Thurman

    Seagen Inc., Bothell, WA, United States.

    Christopher Hale

    Seagen Inc., Bothell, WA, United States.

    Lori Westendorf

    Seattle Genetics, Inc., Bothell, WA, United States.

    Thomas A Pires

    University of Illinois at Urbana-Champaign, Urbana, IL, United States.

    Christopher I Leiske

    Seattle Genetics, Inc., United States.

    Markus Carlson

    Seagen Inc., Bothell, WA, United States.

    Liem T Nguyen

    Seagen Inc., Bothell, WA, United States.

    Julia H Cochran

    Seattle Genetics, Inc., Bothell, WA, United States.

    Nicole M Okeley

    Seattle Genetics (United States), Bothell, WA, United States.

    Roma Yumul

    Seagen Inc., Bothell, WA, United States.

    Steven Jin

    Seattle Genetics, Inc., Bothell, WA, United States.

    Ivan J Stone

    Seattle Genetics, Inc., Bothell, WA, United States.

    Disha Sahetya

    Seagen Inc., Bothell, WA, United States.

    Albina Nesterova

    Seattle Genetics Inc., Bothell, WA, United States.

    Sean Allred

    Seagen Inc., Bothell, WA, United States.

    Kelly M Hensley

    Seagen Inc., Bothell, WA, United States.

    Rachael Hu

    Seagen Inc., Bothell, WA, United States.

    Robert Lawrence

    Seagen Inc., Bothell, WA, United States.

    Timothy S Lewis

    Seagen Inc., Bothell, WA, United States.

    Sharsti Sandall

    Seagen Inc., Bothell, WA, United States.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement